[**2188-10-22**] Exploratory laparotomy, abdominal washout, and closure.
History of Present Illness: The patient is a 72-year-old insulin- dependent diabetic with a BMI of 47, who was diagnosed with rectal cancer found to be T2, N0 by preoperative staging studies.
Because of her obesity, radiation was not a reasonable option and given her T2 status was not recommended.
Physical Exam: Physical Exam on Discharge: Vitals: Temp 98, HR 51, BP 183/71, RR 18, O2 95RA Gen: In NAD, though appears anxious CV: No m/r/g Resp: CTA bilaterally Abd: 15 x 5 cm vertical midline incision with wound VAC in place to suction.
Ext: 1+ bilateral pitting edema  Pertinent Results: [**2188-10-21**] 05:40AM BLOOD WBC-11.4* RBC-3.52* Hgb-11.3* Hct-31.6* MCV-90 MCH-32.2* MCHC-35.8*# RDW-13.1 Plt Ct-201 [**2188-10-22**] 05:15AM BLOOD WBC-18.0*# RBC-3.80* Hgb-12.1 Hct-34.1* MCV-90 MCH-31.9 MCHC-35.6* RDW-13.0 Plt Ct-248 [**2188-10-31**] 05:05AM BLOOD WBC-12.1* RBC-3.22* Hgb-10.0* Hct-30.3* MCV-94 MCH-31.0 MCHC-33.0 RDW-13.6 Plt Ct-357 [**2188-10-28**] 10:30AM BLOOD Neuts-82.3* Lymphs-10.2* Monos-6.6 Eos-0.6 Baso-0.2 [**2188-10-21**] 05:40AM BLOOD Glucose-155* UreaN-9 Creat-1.0 Na-138 K-4.3 Cl-102 HCO3-28 AnGap-12 [**2188-10-31**] 05:05AM BLOOD Glucose-90 UreaN-8 Creat-0.9 Na-142 K-3.7 Cl-108 HCO3-25 AnGap-13 [**2188-10-31**] 05:05AM BLOOD Calcium-7.9* Phos-2.9 Mg-2.1 .
**FINAL REPORT [**2188-10-27**]**     URINE CULTURE (Final [**2188-10-27**]):       YEAST.
WOUND CULTURE (Final [**2188-10-31**]):       MORGANELLA MORGANII.
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              MORGANELLA MORGANII                              | CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S     ANAEROBIC CULTURE (Final [**2188-11-2**]):    NO ANAEROBES ISOLATED.
On exam she was in no acute distress, EKG and CXR were stable and she responded well to nebulizer treatments.
On POD1 she complained of nausea, and an NGT was placed, which she self discontinued multiple times.
Given an equivocal urinalysis and yeast on urine culture, she was started on fluconazole, which was discontinued prior to discharge.
She did have purulent exudate from her vertical midline incision, and wound culture showed MORGANELLA MORGANII.
Her WBC count was downtrending on discharge and she remained afebrile on discharge.
Endocrine: Her finger stick glucoses remained elevated during admission, and she was evaluated by the [**Last Name (un) **] diabetes service who helped adjust her sliding scale.
After IV hydration and close monitoring she was transferred back to the floor the following day.
Medications on Admission: Atenolol 50', bupropion 100'', citalopram 20'qd, gabapentin 600 qid, Lantus 80qam, novolog, lorazepam 1'prn, simvastatin 40' qd, trazodone 75'qhs, Diovan 80 mg-12.5'   Discharge Medications: 1. atenolol 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*60 Tablet(s)* Refills:*0* 15. docusate sodium 50 mg/5 mL Liquid Sig: One (1)  PO BID (2 times a day) for 2 weeks.
BMI of 47.
